Target intelligence / Profile preview

MicroRNA 3615 (miR-3615)

Target
miR-3615
Molecular classification
MicroRNA (miRNA), Non-coding RNA
01

Overview

MicroRNA 3615 (miR-3615) is a short, non-coding RNA belonging to the microRNA family, encoded in the human genome (GeneCards ID: MIR3615, HGNC: 38905, NCBI Gene: 100500847, Ensembl: ENSG00000284186, miRBase: hsa-mir-3615). It exerts its function by regulating gene expression post-transcriptionally, primarily through mRNA targeting and subsequent translation inhibition or mRNA degradation mediated via the RISC complex. Expression of miR-3615 is significantly upregulated in hepatocellular carcinoma, where high levels are associated with worse prognosis, higher TNM stage, higher AFP, and higher Ki-67 expression. It has been proposed as a potential biomarker and therapeutic target for hepatocellular carcinoma. Disease associations also include retinitis pigmentosa and certain syndromic disorders. miR-3615, like many microRNAs, is processed from a longer primary transcript and plays diverse regulatory roles in various tissues.

Other names
MIR3615hsa-mir-3615mir-3615
02

Mechanism of action

Translational repression of target mRNAs; mRNA degradation via RISC pathway

03

Biological functions

Regulation of gene expression (post-transcriptional)Cell proliferationCell differentiationApoptosis (implicated via relation to tumor progression and aggressiveness)
04

Disease associations

Cancer (especially hepatocellular carcinoma and possibly others like follicular lymphoma, colorectal adenocarcinoma)Retinitis pigmentosaAlopecia-intellectual disability syndrome 1Other (Barrett’s esophagus, lymphoid malignancies)
05

Safety considerations

Off-target effects typical of miRNA-based therapeutics (not addressed specifically for miR-3615 in search results)Specific safety challenges not published
06

Biomarkers

Serum alpha-fetoprotein (AFP) in hepatocellular carcinoma for prognosis and diagnosisKi-67 (tumor cell proliferation marker correlation)

Beyond the preview

Go deeper on MicroRNA 3615 (miR-3615).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 3615 (miR-3615).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call